Filing Details
- Accession Number:
- 0000950170-24-105403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 12:53:49
- Reporting Period:
- 2021-12-10
- Accepted Time:
- 2024-09-11 12:53:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1358508 | Norman Sussman | C/O Durect Corporation 10240 Bubb Road Cupertino CA 95014 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-10 | 9,000 | $1.06 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This Form 4 is being filed late due to an inadvertent administrative error. The sale reported herein was executed by the account manager for the benefit of the Reporting Person's managed account, without any instruction from or knowledge of the Reporting Person.
- The number of shares and price are pre-the company's 10:1 reverse stock split and the numbers do not reflect the stock split.